Answers are grounded in this paper and cite their sources.
Highlights advances in molecular mapping of genetic linkages to hypertension, suggesting polygenic insights may improve targeted treatment protocols.
The advancement of molecular biomedical techniques has allowed solutions to the problem of finding a genetic linkage to hypertension. This is now being approached by limiting study to a select number of genetic factors possibly influencing a particular physiologic dysfunction or structural defect. Analysis of chromosomal abnormalities or regions bearing a particular mutation have been greatly influenced by the ability to produce artificial chromosomes or to identify closely linked markers. Rapid accumulation of knowledge of the genetic map has led to a number of these gene/disease linkages. Perhaps the unraveling of some of the polygenic influences in hypertension may lead to even better treatment protocols to minimize the disease complications of elevated blood pressure.
No takes yet. Share an insight, caveat, or question.
Dennis S. Miura (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: